Prevalence of latex sensitization in infants and young children with asthma

Citation
S. Dib et al., Prevalence of latex sensitization in infants and young children with asthma, REV FR ALLE, 41(4), 2001, pp. 382-388
Citations number
38
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
ISSN journal
03357457 → ACNP
Volume
41
Issue
4
Year of publication
2001
Pages
382 - 388
Database
ISI
SICI code
0335-7457(200106)41:4<382:POLSII>2.0.ZU;2-I
Abstract
Purpose. - The hypothesis is that this increasing trend could be linked to sensitization to 'new' allergens such as latex, especially in infants and y oung children. The aim of the study was to Verify the hypothesis that sensi tization to latex is more frequent in asthmatic than in non-asthmatic child ren. Patients and methods, - Two thousand two hundred and fifty-two infants and children less than 6 years of age with asthma were explored consecutively b etween December 1995 and December 1999 regarding: 1) their atopic status by skin testing to usual airborne and food allergens, and specific IgE assay, and 2) more specifically, their sensitization to latex by oriented questio nnaire, skin prick-test with commercial latex extract and anti-latex-specif ic IgE by CAP-System Pharmacia (R). Results. - Twenty-six infants had a latex-positive prick-test. Out of them: I) four had anti-latex-specific IgE, and 2) two experienced urticaria foll owing contact with a rubber balloon and a rubber mattress. Finally, latex s ensitivity was defected only in 2.5% patients with allergic asthma and 0.5% patients with non-allergic asthma. Conclusion. - The results of our study do not support the hypothesis that i ncreasing prevalence of asthma in our country might be due at least in part to latex sensitization. To confirm that clinical symptoms are related to a llergy to latex, prick-tests performed with a commercial extract appear to be less sensitive than specific IgE. (C) 2001 Editions scientifiques et med icales Elsevier SAS.